Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125979282 | 12597928 | 2 | F | 20160819 | 20160727 | 20160824 | EXP | IT-009507513-1607ITA010395 | MERCK | 59.00 | YR | F | Y | 0.00000 | 20160824 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125979282 | 12597928 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | UNK | 21029 | CAPSULE | |||||||||
| 125979282 | 12597928 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | 40 MG/DAY | U | 0 | 40 | MG | TABLET | QD | ||||||
| 125979282 | 12597928 | 3 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | UNK, SECOND LINE | U | 0 | ||||||||||
| 125979282 | 12597928 | 4 | SS | IRINOTECAN HYDROCHLORIDE. | IRINOTECAN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125979282 | 12597928 | 1 | Glioblastoma multiforme |
| 125979282 | 12597928 | 3 | Glioblastoma multiforme |
| 125979282 | 12597928 | 4 | Glioblastoma multiforme |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125979282 | 12597928 | DE |
| 125979282 | 12597928 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125979282 | 12597928 | Herpes simplex encephalitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |